Literature DB >> 16762934

Probiotic use in clinical practice: what are the risks?

Robert J Boyle1, Roy M Robins-Browne, Mimi L K Tang.   

Abstract

Probiotics have been advocated for the prevention and treatment of a wide range of diseases, and there is strong evidence for their efficacy in some clinical scenarios. Probiotics are now widely used in many countries by consumers and in clinical practice. Given the increasingly widespread use of probiotics, a thorough understanding of their risks and benefits is imperative. In this article we review the safety of probiotics and discuss areas of uncertainty regarding their use. Although probiotics have an excellent overall safety record, they should be used with caution in certain patient groups-particularly neonates born prematurely or with immune deficiency. Because of the paucity of information regarding the mechanisms through which probiotics act, appropriate administrative regimens, and probiotic interactions, further investigation is needed in these areas. Finally, note that the properties of different probiotic species vary and can be strain-specific. Therefore, the effects of one probiotic strain should not be generalized to others without confirmation in separate studies. Careful consideration should be given to these issues before patients are advised to use probiotic supplements in clinical practice.

Entities:  

Mesh:

Year:  2006        PMID: 16762934     DOI: 10.1093/ajcn/83.6.1256

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  151 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  A gastroenterologist's guide to probiotics.

Authors:  Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

Review 3.  Probiotics, prebiotics and synbiotics- a review.

Authors:  Kavita R Pandey; Suresh R Naik; Babu V Vakil
Journal:  J Food Sci Technol       Date:  2015-07-22       Impact factor: 2.701

4.  Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.

Authors:  V Sreeja; Jashbhai B Prajapati
Journal:  Probiotics Antimicrob Proteins       Date:  2013-06       Impact factor: 4.609

5.  Use of probiotics in gastrointestinal disorders: what to recommend?

Authors:  Elizabeth C Verna; Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

6.  Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized control trial.

Authors:  James Kinross; Oliver Warren; David Silk; Ara Darzi
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

Review 7.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 8.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

9.  Bacteriotherapy with Lactobacillus plantarum in burns.

Authors:  Maria C Peral; Miguel A Huaman Martinez; Juan C Valdez
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

Review 10.  A review of the economics of treating Clostridium difficile infection.

Authors:  Kari A Mergenhagen; Amy L Wojciechowski; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.